Pfizer targets Omicron variant with new vaccine trial

In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Pfizer and BioNTech are working on a trial to test a modified COVID-19 vaccine aimed at targeting the Omicron variant. Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University Medical Center, joined CBS News to discuss the latest on the pandemic.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting